Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression

Detalles Bibliográficos
Autores principales: Decaens, Thomas, Barone, Carlo, Assenat, Eric, Wermke, Martin, Fasolo, Angelica, Merle, Philippe, Blanc, Jean-Frédéric, Grando, Véronique, Iacobellis, Angelo, Villa, Erica, Trojan, Joerg, Straub, Josef, Bruns, Rolf, Berghoff, Karin, Scheele, Juergen, Raymond, Eric, Faivre, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329044/
https://www.ncbi.nlm.nih.gov/pubmed/34079081
http://dx.doi.org/10.1038/s41416-021-01403-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329044/
https://www.ncbi.nlm.nih.gov/pubmed/34079081
http://dx.doi.org/10.1038/s41416-021-01403-z

Ejemplares similares